p53 and p16INK4A mutations during the progression of glomus tumor
- PMID: 10079377
- DOI: 10.1053/paor.1999.0041
p53 and p16INK4A mutations during the progression of glomus tumor
Abstract
Glomus tumors are significantly rare tumors of carotid body. The great majority of these tumors are benign in character. Here we present two brothers with hereditary glomus jugulare tumor who had consanguineous parents. Radiotherapy was applied approximately 8 and 10 years ago for treatment in both cases. Eight years later, one of these cases came to our notice due to relapse. The mutation pattern of p53, p57KIP2, p16INK4A and p15NK4B genes which have roles in the cell cycle, was analyzed in tumor samples obtained from the two affected cases in the initial phase and from one of these cases at relapse. The DNA sample obtained from the case in initial diagnosis phase revealed no p53, p57KIP2, p16INK4A or p15INK4B mutation. He is still in remission phase. Despite the lack of p53, p57KIP2, p16INK4A and p15INK4B mutation at initial diagnosis the tumor DNA of the other case in relapse revealed p53 codon 243 (ATG-->ATC; met-->ile) and p16 codon 97 (GAC-->AAC; asp-->asn) missense point mutations. No loss of heterozygosity in p53 and p16INK4A was observed by microsatellite analysis of tumoral tissues in these cases. P53 and p16INK4A mutations observed in relapse phase were in conserved regions of both genes. No previous reports have been published with these mutations in glomus tumor during progression. The mutation observed in this case may due to radiotherapy. In spite of this possibility, the missense point mutations in conserved region of p53 and p16INK4A genes may indicate the role of p53 and p16INK4A in tumor progression of glomus tumors.
Similar articles
-
P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.Haematologia (Budap). 1998;29(3):181-93. Haematologia (Budap). 1998. PMID: 10069444
-
Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family.Cancer Genet Cytogenet. 1999 Sep;113(2):145-51. doi: 10.1016/s0165-4608(98)00276-3. Cancer Genet Cytogenet. 1999. PMID: 10484981
-
Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.Cancer. 1998 Nov 15;83(10):2185-93. Cancer. 1998. PMID: 9827724
-
p16ink4a gene and hematological malignancies.Leuk Lymphoma. 1996 Jun;22(1-2):11-24. doi: 10.3109/10428199609051724. Leuk Lymphoma. 1996. PMID: 8724524 Review.
-
Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.Leuk Lymphoma. 1997 Mar;25(1-2):23-35. doi: 10.3109/10428199709042493. Leuk Lymphoma. 1997. PMID: 9130611 Review.
Cited by
-
Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.Endocr Pathol. 2003 Winter;14(4):329-50. doi: 10.1385/ep:14:4:329. Endocr Pathol. 2003. PMID: 14739490 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous